10/2000

 


HCFA Requires Disallowance of Losses Incurred by Nonprofit Hospitals on Mergers and Consolidations

Robert E. Mazer
410-347-7359
remazer@ober.com

In a Medicare Program Memorandum (PM) dated October 19, 2000 (Transmittal No. A-00-76), HCFA specified requirements that must be satisfied before a loss incurred by a nonprofit provider on a merger or consolidation can be reimbursed. According to HCFA, losses should be denied if (1) the governing board or management team of the entity resulting from the transaction includes significant representation from the previous board(s) or management team(s) of the merged or consolidating entities or (2) there is a large disparity between the sales price (for example, liabilities assumed) and the fair market value of the assets transferred, measured using the "cost approach." HCFA asserts that this is not new policy, but only a "clarification" of previous policy. Therefore, the PM instructs intermediaries to "apply this clarification to all cost reports for which a final notice of program reimbursement has not been issued and to all settled cost reports that are subject to reopening..."

HCFA’s most recent "clarification" of Medicare program policy will result in disallowance of numerous loss claims arising from mergers or consolidations. The new requirements are more restrictive than those set forth in draft changes to the Provider Reimbursement Manual on which various intermediaries have relied. They are also more stringent than those included in a draft PM circulated to intermediaries for comment. Loss claims likely to be denied as a result of the PM include those that have already been reimbursed by Medicare intermediaries based on their understanding of Medicare program policy. For those hospitals that have had their loss claims denied, the PM is only the most recent attempt to bolster Medicare’s position through "revisionist" statements of Medicare policy. But for providers which have been reimbursed for losses and have been keeping their fingers crossed until the three-year reopening period has run, the PM’s impact could be more significant—it could lead to reopenings and revised settlements disallowing losses for which reimbursement has already been received.

Background

The Balanced Budget Act of 1997 deleted the statutory requirement that HCFA "provide for recapture of depreciation in the same manner as provided under the regulations in effect on June 1, 1984." Following this legislative change, HCFA amended Medicare regulations to preclude Medicare’s recognition of gains or losses on transactions that occurred on or after December 1, 1997. Based on recent developments, it could be argued forcefully that HCFA is applying this new rule to transactions that preceded December 1, 1997. It might also be argued that HCFA is violating the statutory requirement that, up until that date, losses incurred on statutory mergers or consolidations be reimbursed based on policies that were in effect in 1984.

While the PM is the most comprehensive attempt to require disallowance of loss claims, it is not HCFA’s first attempt to retrospectively "clarify" Medicare policies to disallow loss claims. Notwithstanding previous contrary statements regarding application of generally accepted accounting principles (GAAP), HCFA has recently stated that accounting for a transaction as a "pooling" suggests that the transaction was not a bona fide sale. Similarly, some 20 years after Medicare introduced the term "bona fide sale," HCFA also recently clarified the term to require compensation which was deemed "reasonable" by the Medicare program and "selfish bargaining between the parties."

Program Memorandum

In the PM, HCFA has further clarified Medicare policy to say that, in determining whether a transaction was between related parties, the parties’ relationship when the transaction was negotiated and consummated was irrelevant—related party principles require disallowance of loss claims when there was "significant" carryover of board members or management from participants in a merger or consolidation transaction to the newly created entity. Additionally, according to HCFA, a loss should be disallowed when there is a significant disparity between the purchase price and the appraised value of the assets.

Specifically, HFCA states:

  • In order for Medicare to recognize a gain or loss on a merger or consolidation, the transaction must occur between unrelated parties and the transaction must involve a bona fide sale. Regulations addressing mergers or consolidations between unrelated parties require recognition of a loss, but only if the transaction also qualifies as a bona fide sale.This statement is substantially inconsistent with HCFA correspondence written before HCFA was faced with the prospect of reimbursing a large number of hospitals for losses sustained in change of ownership transactions.
  • The related party regulations require disallowance of a loss if the governing board or management team of the new entity includes significant representation from the previous board(s) or management team(s), even though the two entities did not simultaneously exist. The fact that the parties to the transaction were unrelated prior to the transaction is irrelevant. HCFA states: “[T]he focus of the inquiry should be whether significant ownership or control exists between a corporation that transfers assets and the corporation that receives them.” This statement is inconsistent with the plain language of the regulations, HCFA’s previous application of those regulations, and various published decisions.
  • According to HCFA, for purposes of determining whether a merger or consolidation is a related-party transaction, there are no specific guidelines or “rules of thumb” regarding how “significant” representation is to be determined. Though HCFA purports to rely on established related party principles, the agency appears to disregard related party regulations that say a transaction is between related parties only when an individual or organization has the power to significantly direct the actions or policies of both organizations involved in the transaction. Moreover, HCFA improperly aggregates the collective power of unrelated individuals in determining whether there is significant participation in the new entity by individuals who had been involved in governance of the entity claiming the loss. It also ignores their ability—or lack of ability—to influence or direct the actions of the organization incurring the loss and the entity resulting from the merger or consolidation.
  • HCFA states that a bona fide sale occurs, typically, when the seller spreads word that property may be available for purchase; the seller attempts to maximize consideration and is generally unconcerned with the identity of the purchaser. According to HCFA, Medicare will pay for a loss only if it results from an arms-length business transaction involving "selfish bargaining"; each party must act in its own self-interest. HCFA’s requirements may be contrary to the reality of hospital mergers and consolidations. A hospital that publicizes its availability for purchase may not obtain maximum value for its assets. Moreover, a hospital’s failure to recognize a potential purchaser’s interests and to work towards a "win/win" solution may prevent any transaction from being consummated.
  • The sales price for the assets must be compared with their fair market value. A large disparity indicates the lack of a bona fide sale. Appraisals may establish the fair market value of depreciable assets. The cost approach is the most appropriate methodology, particularly since "the income approach has minimal application in the non-profit sector. . . " HCFA has, essentially, substituted a regulatory requirement that a sale be "bona fide" with a requirement that the sales price closely reflect fair market value computed based on the cost approach. This is inconsistent with various prior decisions.
  • In reviewing the adequacy of the purchase price, total consideration must be allocated first to cash, cash equivalents, and other current assets on a dollar-for-dollar basis, apparently without regard to how the purchase price was allocated in determining the loss. In HCFA’s example, the surviving entity in a statutory merger assumed $22 million of the merged entity’s debts, and received current assets worth $23 million and property, plant, and equipment (PP&E) with a fair market value of $22 million. HCFA would allocate the entire purchase price to the current assets. The loss on PP&E would then be disallowed. While HCFA’s allocation method may reflect GAAP, it has not always been required by Medicare.

HCFA’s regulations preclude recognition of losses occurring on or after December 1, 1997. It is only HCFA’s often suspect interpretation of legal authorities that requires disallowance of losses on earlier transactions. This means that hospitals whose losses are being disallowed are not at a loss for legal, regulatory, and economic arguments that may be used to challenge HCFA’s position. Had HCFA written the PM on a blank slate, it is much more likely that it would be found persuasive by administrative or judicial authorities. However, the regulations and manual provisions at issue—including Medicare related party principles—have been in existence for 20 years or more. They have often been interpreted in a manner that is inconsistent with how HCFA applied them in the PM. Accordingly, providers may be able to establish that the principles on which HCFA relies are inconsistent with the statute and regulations to which the agency is bound, or that they were not in effect at the time of the transaction, let alone on June 1, 1984, as arguably required by statute.

For a copy of the program memorandum, access HCFA’s web site via Ober|Kaler’s web site at www.ober.com. Select "Useful Links," then "Health" to access "Agencies" links.

Robert E. Mazer is a principal in Ober|Kaler's Health Law Department. He can be reached by email at remazer@ober.com or 410-347-7359.

 

 

 

Ober, Kaler, Grimes & Shriver

Maryland
120 East Baltimore Street, Baltimore, MD 21202
Telephone 410-685-1120, Fax 410-547-0699

Washington, D.C.
1401 H Street, NW, Suite 500, Washington, DC 20005
Telephone 202-408-8400, Fax 202-408-0640

Virginia
407 North Washington Street, Suite 105, Falls Church, VA 22046
Telephone 703-237-0126, Fax 202-408-0640